2010
DOI: 10.1016/j.freeradbiomed.2010.01.023
|View full text |Cite
|
Sign up to set email alerts
|

Transduced Tat–SAG fusion protein protects against oxidative stress and brain ischemic insult

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
60
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 60 publications
(61 citation statements)
references
References 47 publications
1
60
0
Order By: Relevance
“…Tat-SOD and SOD were purified as described previously (10,11). Cells seeded in 6-well plates were grown to confluence and treated with or without silk peptide (0.2 μg/ml) for 1 h to assess the effect of silk peptide on the concentration-dependent transduction of Tat-SOD and SOD into HaCaT cells.…”
Section: Transduction Of Sod and Tat-sod Into Hacat Human Keratinocytesmentioning
confidence: 99%
“…Tat-SOD and SOD were purified as described previously (10,11). Cells seeded in 6-well plates were grown to confluence and treated with or without silk peptide (0.2 μg/ml) for 1 h to assess the effect of silk peptide on the concentration-dependent transduction of Tat-SOD and SOD into HaCaT cells.…”
Section: Transduction Of Sod and Tat-sod Into Hacat Human Keratinocytesmentioning
confidence: 99%
“…[23][24][25][26][27][28][29] In a previous study, the TAT protein was used to deliver SOD for the purpose of overcoming certain diseases, such as inflammation or osteoarthritis, and protecting against ischemic brain injury. [30][31][32][33] We developed an arginine-rich peptide, termed low molecular weight protamine (LMWP), which is derived from natural protamine. We demonstrated that LMWP achieved protein transduction in various cell types with activity equivalent to that of unconjugated TAT for molecular imaging and therapeutic purposes.…”
Section: Introductionmentioning
confidence: 99%
“…When forming a complex with other components of SCF/CRL E3 ubiquitin ligases, SAG has E3 ubiquitin ligase activity (15,16,21) and promotes the ubiquitylation and subsequent degradation of various cellular proteins, including p27 (22,23), c-Jun (24), pro-caspase-3 (25), IκBα (16,26), HIF-1α (27), NOXA (28), and NF1 (18) in a cell context-dependent manner. Whole animal studies revealed that SAG overexpression protects mouse brain tissues from ischemia/hypoxia-induced damage (29,30). SAG transgenic expression in mouse skin inhibited tumor formation at the early stage by targeting c-Jun/AP1, but enhanced tumor growth at later stages in a DMBA-TPA carcinogenesis model by targeting IκBα to activate NF-κB (26) and promoted UVB-induced skin hyperplasia by targeting p27 (23).…”
mentioning
confidence: 99%